Moserle, L., Pons, R., Martínez-Lozano, M., Jiménez-Valerio, G. A., Vidal, A., Suárez Rodríguez, C., . . . Carles Galceran, J. (2020). Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits.
Chicago Style CitationMoserle, Lidia, et al. Kidney Cancer PDOXs Reveal Patient-specific Pro-malignant Effects of Antiangiogenics and Its Molecular Traits. 2020.
MLA CitationMoserle, Lidia, et al. Kidney Cancer PDOXs Reveal Patient-specific Pro-malignant Effects of Antiangiogenics and Its Molecular Traits. 2020.
Warning: These citations may not always be 100% accurate.